We are live on ! Find out more
BBP icon

Virtus Biotech ETF
BBP

13 hedge funds and large institutions have $6.14M invested in Virtus Biotech ETF in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more capital invested

Capital invested by funds: $4.83M → $6.14M (+$1.32M)

5.36% more ownership

Funds ownership: 27.99% → 33.36% (+5.4%)

7% less funds holding

Funds holding: 14 → 13 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FEM
Fulcrum Equity Management
Texas
+$1.39M
2
Morgan Stanley
Morgan Stanley
New York
+$1.33M
3
LCGC
Legacy Capital Group California
California
+$496K
4
GEA
Glen Eagle Advisors
New Jersey
+$2.62K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.8M
2
MIFH
Migdal Insurance & Financial Holdings
Israel
-$136K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$107K
4
LPL Financial
LPL Financial
California
-$31.9K
5
Stifel Financial
Stifel Financial
Missouri
-$13.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$2.26M +$1.33M +25,385 +145%
FEM
2
Fulcrum Equity Management
Texas
$1.39M +$1.39M +26,466 New
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$812K -$9.55K -182 -1%
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$565K -$107K -2,030 -16%
LCGC
5
Legacy Capital Group California
California
$498K +$496K +9,461 New
LPL Financial
6
LPL Financial
California
$254K -$31.9K -608 -11%
Stifel Financial
7
Stifel Financial
Missouri
$219K -$13.2K -252 -6%
Osaic Holdings
8
Osaic Holdings
Arizona
$65.2K – – –
Carson Wealth (CWM LLC)
9
Carson Wealth (CWM LLC)
Nebraska
$29K – – –
DSC
10
Duncker Streett & Co
Missouri
$28.1K – – –
Northwestern Mutual Wealth Management
11
Northwestern Mutual Wealth Management
Wisconsin
$10.9K – – –
FWM
12
Focused Wealth Management
New York
$10.5K – – –
GEA
13
Glen Eagle Advisors
New Jersey
$2.63K +$2.62K +50 New
Citadel Advisors
14
Citadel Advisors
Florida
– -$1.8M -36,512 Closed
MIFH
15
Migdal Insurance & Financial Holdings
Israel
– -$136K -2,780 Closed
UBS Group
16
UBS Group
Switzerland
– -$8.62K -175 Closed
BAM
17
Belpointe Asset Management
Nevada
– -$2.27K -46 Closed

BBP Hedge Fund Activity: Q2 2023 in Review

13 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q2 2023, worth a combined $6.14M — up 27% from $4.83M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BBP and 3 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.

The largest buyer was Fulcrum Equity Management, opening a new position worth an estimated $1.39M. The largest seller was Citadel Advisors, exiting entirely with an estimated $1.8M sold.

  • 13 institutional investors held Virtus Biotech ETF (BBP) as of Q2 2023, down from 14 in Q1 2023.
  • Funds reported $6.14M of Virtus Biotech ETF stock for Q2 2023, up 27% quarter-over-quarter.
  • 3 funds opened new Virtus Biotech ETF positions in Q2 2023 and 4 closed out, a net change of -1 holder.
  • The largest Virtus Biotech ETF buyer in Q2 2023 was Fulcrum Equity Management, an estimated $1.39M added.
  • The largest Virtus Biotech ETF seller in Q2 2023 was Citadel Advisors, an estimated $1.8M sold.

Based on aggregated 13F filings for Q2 2023.